Able 0 4 0 4 O
, 4 5 4 5 O
willing 6 13 6 13 O
to 14 16 14 16 O
give 17 21 17 21 O
written 22 29 22 29 O
consent 30 37 30 37 O
for 38 41 38 41 O
available 42 51 42 51 O
archival 52 60 52 60 O
tumor 61 66 61 66 O
samples 67 74 67 74 O
( 75 76 75 76 O
not 76 79 76 79 O
mandatory 80 89 80 89 O
) 89 90 89 90 O
and 91 94 91 94 O
tumor 95 100 95 100 B-treatment
biopsies 101 109 101 109 I-treatment
before 110 116 110 116 O
and 117 120 117 120 O
during 121 127 121 127 O
protocol 128 136 128 136 B-treatment
therapy 137 144 137 144 I-treatment
( 145 146 145 146 O
mandatory 146 155 146 155 O
) 155 156 155 156 O

Active 0 6 157 163 O
or 7 9 164 166 O
prior 10 15 167 172 O
documented 16 26 173 183 O
autoimmune 27 37 184 194 B-clinical_variable
disease 38 45 195 202 I-clinical_variable
within 46 52 203 209 O
the 53 56 210 213 O
past 57 61 214 218 B-upper_bound
2 62 63 219 220 I-upper_bound
years 64 69 221 226 I-upper_bound

Age 0 3 227 230 B-age
> 4 5 231 232 O
18 6 8 233 235 B-lower_bound
years 9 14 236 241 I-lower_bound
at 15 17 242 244 O
time 18 22 245 249 O
of 23 25 250 252 O
study 26 31 253 258 O
entry 32 37 259 264 O

Concurrent 0 10 265 275 O
administration 11 25 276 290 O
of 26 28 291 293 O
strong 29 35 294 300 B-treatment
inhibitors 36 46 301 311 I-treatment
or 47 49 312 314 I-treatment
moderate 50 58 315 323 I-treatment
inducers 59 67 324 332 I-treatment
of 68 70 333 335 I-treatment
CYP1A2 71 77 336 342 I-treatment
is 78 80 343 345 O
not 81 84 346 349 O
permitted 85 94 350 359 O
; 94 95 359 360 O
administration 96 110 361 375 O
must 111 115 376 380 O
be 116 118 381 383 O
discontinued 119 131 384 396 O
at 132 134 397 399 O
least 135 140 400 405 O
7 141 142 406 407 B-lower_bound
days 143 147 408 412 I-lower_bound
prior 148 153 413 418 I-lower_bound
to 154 156 419 421 O
initiating 157 167 422 432 O
study 168 173 433 438 B-treatment
drug 174 178 439 443 I-treatment
administration 179 193 444 458 O

Concurrent 0 10 459 469 O
use 11 14 470 473 O
of 15 17 474 476 O
other 18 23 477 482 O
anticancer 24 34 483 493 B-treatment
approved 35 43 494 502 O
or 44 46 503 505 O
investigational 47 62 506 521 B-treatment
agents 63 69 522 528 I-treatment

EGFR 0 4 529 533 O
mutation 5 13 534 542 O
with 14 18 543 547 O
exon 19 23 548 552 O
19 24 26 553 555 O
deletion 27 35 556 564 O
or 36 38 565 567 O
L858R 39 44 568 573 O
mutation 45 53 574 582 O
( 54 55 583 584 O
Exon 55 59 584 588 O
21 60 62 589 591 O
) 62 63 591 592 O
or 64 66 593 595 O
ALK 67 70 596 599 O
rearrangement 71 84 600 613 O
positive 85 93 614 622 O
must 94 98 623 627 O
have 99 103 628 632 O
failed 104 110 633 639 O
prior 111 116 640 645 B-treatment
TKI 117 120 646 649 I-treatment
therapy 121 128 650 657 I-treatment

Eastern 0 7 658 665 B-clinical_variable
Cooperative 8 19 666 677 I-clinical_variable
Oncology 20 28 678 686 I-clinical_variable
Group 29 34 687 692 I-clinical_variable
( 35 36 693 694 I-clinical_variable
ECOG 36 40 694 698 I-clinical_variable
) 40 41 698 699 I-clinical_variable
0 42 43 700 701 B-lower_bound
- 43 44 701 702 O
1 44 45 702 703 B-upper_bound

Female 0 6 704 710 B-gender
patients 7 15 711 719 I-gender
must 16 20 720 724 O
either 21 27 725 731 O
be 28 30 732 734 O
of 31 33 735 737 O
non 34 37 738 741 O
- 37 38 741 742 O
reproductive 38 50 742 754 O
potential 51 60 755 764 O
( 61 62 765 766 O
ie 62 64 766 768 O
, 64 65 768 769 O
post 66 70 770 774 O
- 70 71 774 775 O
menopausal 71 81 775 785 O
by 82 84 786 788 O
history 85 92 789 796 O
: 92 93 796 797 O
≥60 94 97 798 801 O
years 98 103 802 807 I-lower_bound
old 104 107 808 811 O
or 108 110 812 814 O
no 111 113 815 817 O
menses 114 120 818 824 O
for 121 124 825 828 O
1 125 126 829 830 B-upper_bound
year 127 131 831 835 I-upper_bound
without 132 139 836 843 O
an 140 142 844 846 O
alternative 143 154 847 858 O
medical 155 162 859 866 O
cause 163 168 867 872 O

Measurable 0 10 873 883 O
disease 11 18 884 891 O
, 18 19 891 892 O
defined 20 27 893 900 O
as 28 30 901 903 O
at 31 33 904 906 O
least 34 39 907 912 O
one 40 43 913 916 B-lower_bound
lesion 44 50 917 923 O
that 51 55 924 928 O
can 56 59 929 932 O
be 60 62 933 935 O
accurately 63 73 936 946 O
measured 74 82 947 955 O
in 83 85 956 958 O
at 86 88 959 961 O
least 89 94 962 967 O
one 95 98 968 971 O
dimension 99 108 972 981 O
( 109 110 982 983 O
longest 110 117 983 990 O
diameter 118 126 991 999 O
to 127 129 1000 1002 O
be 130 132 1003 1005 O
recorded 133 141 1006 1014 O
for 142 145 1015 1018 O
non 146 149 1019 1022 O
- 149 150 1022 1023 O
nodal 150 155 1023 1028 O
lesions 156 163 1029 1036 O
and 164 167 1037 1040 O
short 168 173 1041 1046 O
axis 174 178 1047 1051 O
for 179 182 1052 1055 O
nodal 183 188 1056 1061 O
lesions 189 196 1062 1069 O
) 196 197 1069 1070 O
as 198 200 1071 1073 O
> 201 202 1074 1075 O
20 202 204 1075 1077 B-lower_bound
mm 205 207 1078 1080 I-lower_bound
with 208 212 1081 1085 O
conventional 213 225 1086 1098 B-treatment
techniques 226 236 1099 1109 I-treatment
or 237 239 1110 1112 O
as 240 242 1113 1115 O
> 243 244 1116 1117 O
10 244 246 1117 1119 B-lower_bound
mm 247 249 1120 1122 I-lower_bound
with 250 254 1123 1127 O
spiral 255 261 1128 1134 B-treatment
computed 262 270 1135 1143 I-treatment
tomography 271 281 1144 1154 I-treatment
( 282 283 1155 1156 I-treatment
CT 283 285 1156 1158 I-treatment
) 285 286 1158 1159 I-treatment
scan 287 291 1160 1164 I-treatment
, 291 292 1164 1165 O
Magnetic 293 301 1166 1174 B-treatment
resonance 302 311 1175 1184 I-treatment
imaging 312 319 1185 1192 I-treatment
( 320 321 1193 1194 I-treatment
MRI 321 324 1194 1197 I-treatment
) 324 325 1197 1198 I-treatment
, 325 326 1198 1199 O
or 327 329 1200 1202 O
calipers 330 338 1203 1211 B-clinical_variable
by 339 341 1212 1214 O
clinical 342 350 1215 1223 O
exam 351 355 1224 1228 O

Patients 0 8 1229 1237 O
must 9 13 1238 1242 O
have 14 18 1243 1247 O
histologic 19 29 1248 1258 O
or 30 32 1259 1261 O
cytologic 33 42 1262 1271 O
diagnosis 43 52 1272 1281 O
of 53 55 1282 1284 O
advanced 56 64 1285 1293 B-cancer
/ 64 65 1293 1294 I-cancer
metastatic 65 75 1294 1304 I-cancer
NSCLC 76 81 1305 1310 I-cancer
. 81 82 1310 1311 O
For 83 86 1312 1315 O
those 87 92 1316 1321 O
with 93 97 1322 1326 O
mixed 98 103 1327 1332 O
histology 104 113 1333 1342 O
, 113 114 1342 1343 O
there 115 120 1344 1349 O
must 121 125 1350 1354 O
be 126 128 1355 1357 O
a 129 130 1358 1359 O
predominant 131 142 1360 1371 O
histology 143 152 1372 1381 O

Patients 0 8 1382 1390 O
must 9 13 1391 1395 O
previously 14 24 1396 1406 O
have 25 29 1407 1411 O
received 30 38 1412 1420 O
at 39 41 1421 1423 O
least 42 47 1424 1429 O
one 48 51 1430 1433 B-lower_bound
prior 52 57 1434 1439 B-treatment
line 58 62 1440 1444 I-treatment
of 63 65 1445 1447 I-treatment
therapy 66 73 1448 1455 I-treatment
for 74 77 1456 1459 O
their 78 83 1460 1465 O
disease 84 91 1466 1473 O

Patients 0 8 1474 1482 O
receiving 9 18 1483 1492 O
systemic 19 27 1493 1501 B-treatment
steroids 28 36 1502 1510 I-treatment
≥ 37 38 1511 1512 O
10mg 39 43 1513 1517 B-lower_bound
/ 43 44 1517 1518 I-lower_bound
day 44 47 1518 1521 I-lower_bound
of 48 50 1522 1524 O
prednisone 51 61 1525 1535 B-treatment
or 62 64 1536 1538 O
the 65 68 1539 1542 O
equivalent 69 79 1543 1553 O

Patients 0 8 1554 1562 O
with 9 13 1563 1567 O
vitiligo 14 22 1568 1576 B-chronic_disease
, 22 23 1576 1577 O
Grave 24 29 1578 1583 B-chronic_disease
's 29 31 1583 1585 I-chronic_disease
disease 32 39 1586 1593 I-chronic_disease
, 39 40 1593 1594 O
or 41 43 1595 1597 O
psoriasis 44 53 1598 1607 B-chronic_disease
not 54 57 1608 1611 O
requiring 58 67 1612 1621 O
systemic 68 76 1622 1630 B-treatment
treatment 77 86 1631 1640 I-treatment
( 87 88 1641 1642 O
within 88 94 1642 1648 O
the 95 98 1649 1652 O
past 99 103 1653 1657 B-upper_bound
2 104 105 1658 1659 I-upper_bound
years 106 111 1660 1665 I-upper_bound
) 111 112 1665 1666 O

Pregnancy 0 9 1667 1676 B-pregnancy

Prior 0 5 1677 1682 B-treatment
immunotherapy 6 19 1683 1696 I-treatment
is 20 22 1697 1699 O
allowed 23 30 1700 1707 O
( 31 32 1708 1709 O
previous 32 40 1709 1717 B-treatment
immune 41 47 1718 1724 I-treatment
checkpoint 48 58 1725 1735 I-treatment
inhibitors 59 69 1736 1746 I-treatment
; 69 70 1746 1747 O
anti 71 75 1748 1752 B-treatment
- 75 76 1752 1753 I-treatment
CTLA-4 76 82 1753 1759 I-treatment
, 82 83 1759 1760 O
anti 84 88 1761 1765 B-treatment
- 88 89 1765 1766 I-treatment
PD-1 89 93 1766 1770 I-treatment
, 93 94 1770 1771 O
anti 95 99 1772 1776 B-treatment
- 99 100 1776 1777 I-treatment
PD 100 102 1777 1779 I-treatment
- 102 103 1779 1780 I-treatment
L1 103 105 1780 1782 I-treatment
and/or 106 112 1783 1789 O
combinations 113 125 1790 1802 O
) 125 126 1802 1803 O

Prior 0 5 1804 1809 O
malignancy 6 16 1810 1820 B-cancer
in 17 19 1821 1823 O
past 20 24 1824 1828 B-upper_bound
2 25 26 1829 1830 I-upper_bound
years 27 32 1831 1836 I-upper_bound
or 33 35 1837 1839 O
as 36 38 1840 1842 O
identified 39 49 1843 1853 O
in 50 52 1854 1856 O
Section 53 60 1857 1864 O
7.2 61 64 1865 1868 O
of 65 67 1869 1871 O
this 68 72 1872 1876 O
protocol 73 81 1877 1885 O

Serious 0 7 1886 1893 O
uncontrolled 8 20 1894 1906 O
medical 21 28 1907 1914 B-chronic_disease
disorder 29 37 1915 1923 I-chronic_disease
or 38 40 1924 1926 O
active 41 47 1927 1933 B-chronic_disease
infection 48 57 1934 1943 I-chronic_disease
that 58 62 1944 1948 O
in 63 65 1949 1951 O
the 66 69 1952 1955 O
investigator 70 82 1956 1968 O
's 82 84 1968 1970 O
opinion 85 92 1971 1978 O
would 93 98 1979 1984 O
impair 99 105 1985 1991 O
the 106 109 1992 1995 O
patient 110 117 1996 2003 O
's 117 119 2003 2005 O
ability 120 127 2006 2013 O
to 128 130 2014 2016 O
receive 131 138 2017 2024 O
study 139 144 2025 2030 O
treatment 145 154 2031 2040 B-treatment

Smoking 0 7 2041 2048 O
( 8 9 2049 2050 O
cigarettes 9 19 2050 2060 O
, 19 20 2060 2061 O
cigars 21 27 2062 2068 O
or 28 30 2069 2071 O
pipes 31 36 2072 2077 O
) 36 37 2077 2078 O
must 38 42 2079 2083 O
be 43 45 2084 2086 O
discontinued 46 58 2087 2099 O
at 59 61 2100 2102 O
least 62 67 2103 2108 O
7 68 69 2109 2110 B-lower_bound
days 70 74 2111 2115 I-lower_bound
prior 75 80 2116 2121 I-lower_bound
to 81 83 2122 2124 O
initiating 84 94 2125 2135 O
study 95 100 2136 2141 O
drug 101 105 2142 2146 O
administration 106 120 2147 2161 O
; 120 121 2161 2162 O
smoking 122 129 2163 2170 O
cessation 130 139 2171 2180 O
products 140 148 2181 2189 O
( 149 150 2190 2191 O
transdermal 150 161 2191 2202 O
nicotine 162 170 2203 2211 O
patches 171 178 2212 2219 O
or 179 181 2220 2222 O
chewing 182 189 2223 2230 O
gum 190 193 2231 2234 O
may 194 197 2235 2238 O
be 198 200 2239 2241 O
used 201 205 2242 2246 O
) 205 206 2246 2247 O

Subject 0 7 2248 2255 O
is 8 10 2256 2258 O
willing 11 18 2259 2266 O
and 19 22 2267 2270 O
able 23 27 2271 2275 O
to 28 30 2276 2278 O
comply 31 37 2279 2285 O
with 38 42 2286 2290 O
the 43 46 2291 2294 O
protocol 47 55 2295 2303 O
for 56 59 2304 2307 O
the 60 63 2308 2311 O
duration 64 72 2312 2320 O
of 73 75 2321 2323 O
the 76 79 2324 2327 O
study 80 85 2328 2333 O
including 86 95 2334 2343 O
undergoing 96 106 2344 2354 O
treatment 107 116 2355 2364 B-treatment
and 117 120 2365 2368 O
scheduled 121 130 2369 2378 O
visits 131 137 2379 2385 O
and 138 141 2386 2389 O
examinations 142 154 2390 2402 O
including 155 164 2403 2412 O
follow 165 171 2413 2419 O
up 172 174 2420 2422 O

Symptomatic 0 11 2423 2434 O
and/or 12 18 2435 2441 O
untreated 19 28 2442 2451 O
Brain 29 34 2452 2457 B-cancer
Metastases 35 45 2458 2468 I-cancer

Women 0 5 2469 2474 B-gender
of 6 8 2475 2477 O
child 9 14 2478 2483 O
- 14 15 2483 2484 O
bearing 15 22 2484 2491 O
potential 23 32 2492 2501 O
, 32 33 2501 2502 O
defined 34 41 2503 2510 O
as 42 44 2511 2513 O
all 45 48 2514 2517 O
women 49 54 2518 2523 B-gender
physiologically 55 70 2524 2539 O
capable 71 78 2540 2547 O
of 79 81 2548 2550 O
becoming 82 90 2551 2559 B-pregnancy
pregnant 91 99 2560 2568 I-pregnancy
, 99 100 2568 2569 O
must 101 105 2570 2574 O
use 106 109 2575 2578 B-contraception_consent
2 110 111 2579 2580 I-contraception_consent
highly 112 118 2581 2587 I-contraception_consent
effective 119 128 2588 2597 I-contraception_consent
methods 129 136 2598 2605 I-contraception_consent
of 137 139 2606 2608 I-contraception_consent
contraception 140 153 2609 2622 I-contraception_consent
while 154 159 2623 2628 O
taking 160 166 2629 2635 O
study 167 172 2636 2641 O
treatment 173 182 2642 2651 B-treatment
and 183 186 2652 2655 O
for 187 190 2656 2659 O
90 191 193 2660 2662 B-upper_bound
days 194 198 2663 2667 I-upper_bound
after 199 204 2668 2673 I-upper_bound
the 205 208 2674 2677 O
last 209 213 2678 2682 O
dose 214 218 2683 2687 O
of 219 221 2688 2690 O
study 222 227 2691 2696 O
treatment 228 237 2697 2706 O

history 0 7 2707 2714 O
of 8 10 2715 2717 O
bilateral 11 20 2718 2727 B-treatment
oophorectomy 21 33 2728 2740 I-treatment
) 33 34 2740 2741 O
or 35 37 2742 2744 O
must 38 42 2745 2749 O
have 43 47 2750 2754 O
a 48 49 2755 2756 O
negative 50 58 2757 2765 B-pregnancy
serum 59 64 2766 2771 I-pregnancy
pregnancy 65 74 2772 2781 I-pregnancy
test 75 79 2782 2786 O
upon 80 84 2787 2791 O
study 85 90 2792 2797 O
entry 91 96 2798 2803 O

history 0 7 2804 2811 O
of 8 10 2812 2814 O
bilateral 11 20 2815 2824 B-treatment
tubal 21 26 2825 2830 I-treatment
ligation 27 35 2831 2839 I-treatment

history 0 7 2840 2847 O
of 8 10 2848 2850 O
complete 11 19 2851 2859 O
hysterectomy 20 32 2860 2872 B-treatment

the 0 3 2873 2876 O
patients 4 12 2877 2885 O
enrolled 13 21 2886 2894 O
to 22 24 2895 2897 O
the 25 28 2898 2901 O
immunotherapy 29 42 2902 2915 B-treatment
naïve 43 48 2916 2921 O
group 49 54 2922 2927 O
of 55 57 2928 2930 O
the 58 61 2931 2934 O
phase 62 67 2935 2940 O
IB 68 70 2941 2943 O
dose 71 75 2944 2948 O
expansion 76 85 2949 2958 O

